Cardiovascular Morbidity in Diabetic Non-Alcoholic Fatty Liver Disease (NAFLD) Using NAFLD Fibrosis Score as an Early Indicator
Priti SHAHAPURE, Shimpa SHARMA
(Endocrinol Res Pract 2020; 24: 314-320) DOI: 10.25179/tjem.2020-77679
Priti SHAHAPURE, Shimpa SHARMA
(Endocrinol Res Pract 2020; 24: 314-320) DOI: 10.25179/tjem.2020-77679